徳島大学 / 教育研究者総覧 --- 山田直輝

検索:

徳島大学 ⟩ 病院 ⟩ 先端医療開発研究プロジェクト ⟩
徳島大学 ⟩ 病院 ⟩ 診療科 ⟩ 脳·神経·精神科 ⟩ 精神科神経科 ⟩
徳島大学 ⟩ 病院 ⟩ 診療科 ⟩ 脳·神経·精神科 ⟩ 心身症科 ⟩
徳島大学 ⟩ 医学部 ⟩ 医学科 ⟩ 情報統合医学講座 ⟩ 精神医学分野 ⟩

(researchmapへのインポート用ファイル) [PDF解説] [researchmapへの自動反映について]

研究活動

専門分野

研究テーマ

著書・論文

学術論文(審査論文):

1.	Toshiaki Onitsuka, Tsuyoshi Okada, Naomi Hasegawa, Takashi Tsuboi, Junichi Iga, Norio Yasui-Furukori, Naoki Yamada, Hikaru Hori, Hiroyuki Muraoka, Kazutaka Ohi, Kazuyoshi Ogasawara, Shinichiro Ochi, Masahiro Takeshima, Kayo Ichihashi, Kentaro Fukumoto, Hitoshi Iida, Hisashi Yamada, Ryuji Furihata, Manabu Makinodan, Yoshikazu Takaesu, Shusuke Numata, Hiroshi Komatsu, Akitoyo Hishimoto, Mikio Kido, Kiyokazu Atake, Hirotaka Yamagata, Saya Kikuchi, Naoki Hashimoto, Masahide Usami, Eiichi Katsumoto, Takeshi Asami, Chika Kubota, Junya Matsumoto, Kenichiro Miura, Yoji Hirano, Koichiro Watanabe, Ken Inada and Ryota Hashimoto : Combination Psychotropic Use for Schizophrenia With Long-Acting Injectable Antipsychotics and Oral Antipsychotics: A Nationwide Real-World Study in Japan., Journal of Clinical Psychopharmacology, Vol.43, No.4, 365-368, 2023. (要約) Presenting these real-world clinical results, we want to encourage clinicians to keep monotherapy in mind for the treatment of schizophrenia, especially by reducing concomitant use of antipsychotics in the LAI group and reducing hypnotic and/or antianxiety medication in the non-LAI group. (キーワード) Humans / Antipsychotic Agents / 統合失調症 (schizophrenia) / 日本 (Japan) / Injections / Administration, Oral / Hypnotics and Sedatives / Delayed-Action Preparations (出版サイトへのリンク) ● Publication site (DOI): 10.1097/JCP.0000000000001704 (文献検索サイトへのリンク) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 37216369 ● Search Scopus @ Elsevier (PMID): 37216369 ● Search Scopus @ Elsevier (DOI): 10.1097/JCP.0000000000001704 (DOI: 10.1097/JCP.0000000000001704, PubMed: 37216369)
2.	Hidehiro Umehara, Tomoya Takeda, Leona Yoshida, Kanae Matsuura, Mika Okumura-Fujita, Ryuta Tominaga, Yasuko Abe, Tarishi Masuda, Naoki Yamada and Shusuke Numata : Effects of group therapy on jumping to conclusion bias in adolescents with autism spectrum disorder: An exploratory study., The Journal of Medical Investigation : JMI, Vol.70, No.1.2, 115-122, 2023. (要約) Jumping to conclusion (JTC)-a cognitive bias in thinking processes-leads to drawing conclusions based on little information, and could be related to psychosis and paranoia. While it has recently been pointed out that it could accompany the autism spectrum disorder (ASD), no interventions targeting this bias in adolescents with ASD have been reported. Therefore, this exploratory study investigated the effects of a group social cognition program on JTC bias in adolescents with ASD. Group rehabilitation using social cognition and interaction training (SCIT) was conducted for 12- to 18-year-old adolescents with ASD. An SCIT program comprehensively targets social cognitive functions, including interventions for JTC bias, and examines changes before and after the SCIT intervention, social cognitive functioning tasks, and subjective quality of life (QOL). Thirteen adolescents with ASD participated in this program ; 10 (76.9%) stayed through it. The proportion of participants with JTC bias decreased significantly before and after SCIT (before : 7/10 ; after : 1/10 ; p = 0.041), and subjective QOL increased significantly (p=0.014). The results show that a group social cognition program with a JTC bias approach improves the JTC bias and increases subjective QOL in adolescents with ASD. J. Med. Invest. 70 : 115-122, February, 2023. (キーワード) Humans / Adolescent / Child / Quality of Life / Autism Spectrum Disorder / Cognition / Psychotherapy, Group (徳島大学機関リポジトリ) ● Metadata: 118333 (出版サイトへのリンク) ● Publication site (DOI): 10.2152/jmi.70.115 (文献検索サイトへのリンク) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 37164706 ● Summary page in Scopus @ Elsevier: 2-s2.0-85158825245 (徳島大学機関リポジトリ: 118333, DOI: 10.2152/jmi.70.115, PubMed: 37164706, Elsevier: Scopus)
3.	Naoki Yamada, Yoshihiro Nakadoi, Ryosuke Fukuma and Tetsuro Ohmori : Two children exhibiting social withdrawal, school refusal, and underlying generalized anxiety disorder successfully treated using a selective serotonin reuptake inhibitor., The Journal of Medical Investigation : JMI, Vol.67, No.3.4, 355-357, 2020. (要約) Generalized anxiety disorder (GAD) sometimes exists in the background of social withdrawal and school refusal. Although clinical evidence suggests that selective serotonin reuptake inhibitors (SSRIs) are an effective treatment for GAD, they are not officially approved for GAD in Japan. In addition, it has been established that the use of SSRIs increases the risk for suicide and activation syndrome among young individuals. As such, there is currently little domestic clinical experience in prescribing SSRIs to young patients with GAD. The authors report two cases involving 10-year-old patients with GAD who were treated successfully with escitalopram and experienced subsequent improvement in social withdrawal and school refusal. One patient had autistic spectrum disorder and exhibited self-harm associated with anxiety symptoms, requiring careful use of SSRIs under hospitalization. The other patient was treated at an outpatient clinic without any side effects. In each case, improvement of anxiety symptoms with the use of SSRIs facilitated the introduction of psychoeducation and psychotherapy. It is important to accurately diagnose GAD, which may exist in the background of patients exhibiting social withdrawal and school refusal, and to treat the disorder appropriately. J. Med. Invest. 67 : 355-357, August, 2020. (徳島大学機関リポジトリ) ● Metadata: 115453 (出版サイトへのリンク) ● Publication site (DOI): 10.2152/jmi.67.355 (文献検索サイトへのリンク) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 33148915 ● Search Scopus @ Elsevier (PMID): 33148915 ● Search Scopus @ Elsevier (DOI): 10.2152/jmi.67.355 (徳島大学機関リポジトリ: 115453, DOI: 10.2152/jmi.67.355, PubMed: 33148915)

総説・解説:

1.	中山知彦, 富岡有紀子, 山田直輝, 梅原英裕, 木下誠, 中瀧理仁, 沼田周助 : 臨床現場におけるたとえ話, 精神科治療学, Vol.37, No.7, 745-749, 2022年.

国際会議:

1.	Hidehiro Umehara, Tomoya Takeda, Matsuura Kanae, Abe Yasuko, Masuda Tarishi, Naoki Yamada and Shusuke Numata : Effectiveness of the group social cognition program on jumping to conclusion bias in adolescents with autism spectrum disorder., The 11th ASCAPAP, May 2023.

国内講演発表:

1.	鬼塚俊明, 岡田剛史, 長谷川尚美, 坪井貴嗣, 伊賀淳一, 古郡規雄, 山田直輝, 堀輝, 村岡寛之, 大井一高, 小笠原一能, 越智紳一郎, 竹島正浩, 市橋香代, 福本健太郎, 飯田仁志, 山田恒, 降籏隆二, 牧之段学, 高江洲義和, 沼田周助, 小松浩, 菱本明豊, 木戸幹雄, 阿竹聖和, 山形弘隆, 菊地紗耶, 橋本直樹, 宇佐美政英, 勝元榮一, 浅見剛, 久保田智香, 松本純弥, 三浦健一郎, 平野羊嗣, 渡邊衡一郎, 稲田健, 橋本亮太 : 持続性抗精神病注射薬剤(LAI)と経口抗精神病薬の併用薬の状況:日本における実態調査, 第17回日本統合失調症学会, 2023年3月.
2.	中瀧理仁, 山田直輝, 原田紗希, 沼田周助 : 希死念慮が急性期ACP(Advance Care Planning)に影響した一症例, 第35回日本総合病院精神医学会総会, 2022年10月.
3.	梅原英裕, 中村公哉, 武田知也, 山田直輝 : 青年期自閉スペクトラム症の社会性の障害とヒント課題の関連, 第62回日本児童青年精神医学会, 2021年11月.
4.	中村公哉, 梅原英裕, 武田知也, 山田直輝 : 精神疾患を抱える子ども達の不登校の背景にある要因, 第62回日本児童青年精神医学会, 2021年11月.

作品:

1.	山田直輝 : 不登校のこどもたちとその関わり, めんたる・へるす, Vol.69, 12-17, 2020年.

その他・研究会:

1.	梅原英裕, 武田知也, 山田直輝, 中村公哉, 松浦可苗, 冨永隆太, 阿部恭子 : ヒント課題を用いた中高生における心の理論の評価, 第20回精神疾患と認知機能研究会, 2022年2月.

科学研究費補助金 (KAKEN Grants Database @ NII.ac.jp)

研究者番号（00896590）による検索